NAVIGATING ASSET TRANSITIONS THAT INCLUDE EAPs

A common challenge for many companies during asset movements is the transition of Expanded Access Programs (EAPs). EAPs are often overlooked in the initial agreements and transition plans, leading to confusion and inefficiency at best, and vulnerable patient supply chains at worst.

This guide is designed for the pharmaceutical professional who wants to master the art of managing asset transitions, with an emphasis on the seamless transition of EAPs. We will explore actionable steps to ensure that these critical programs traverse company boundaries with efficiency, compliance and, most importantly, patient care at the core.